|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004153,
umls-concept:C0030705,
umls-concept:C0065055,
umls-concept:C0087111,
umls-concept:C0162577,
umls-concept:C0201950,
umls-concept:C0286651,
umls-concept:C0332152,
umls-concept:C0332281,
umls-concept:C0428466,
umls-concept:C0542560,
umls-concept:C0741968,
umls-concept:C1261287
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-7-30
|
|
pubmed:abstractText |
Oxidized low-density lipoprotein (oxLDL) is a pivotal factor of the atheromatous process. Statins reduce atheromatosis and cardiovascular risk. The aim of the present study was to investigate the effect of statin therapy on circulating oxLDL and the possible impact of such effect on stenosis due to carotid artery atheromatosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1827-1839
|
|
pubmed:author |
pubmed-author:DermitzakisII,
pubmed-author:DrakoulisCC,
pubmed-author:GialerniosKK,
pubmed-author:GialerniosTT,
pubmed-author:GikaEE,
pubmed-author:IliopoulosNN,
pubmed-author:KatsadorouEE,
pubmed-author:KougialisSS,
pubmed-author:KroustalisAA,
pubmed-author:MpilinisHH,
pubmed-author:NikolaouSS,
pubmed-author:PolydorouAA,
pubmed-author:PolydorouVV,
pubmed-author:SkopelitisEE,
pubmed-author:ZervosGG
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
338-47
|
|
pubmed:meshHeading |
pubmed-meshheading:20671652-Aged,
pubmed-meshheading:20671652-Aged, 80 and over,
pubmed-meshheading:20671652-Angioplasty,
pubmed-meshheading:20671652-Biological Markers,
pubmed-meshheading:20671652-Carotid Stenosis,
pubmed-meshheading:20671652-Cross-Sectional Studies,
pubmed-meshheading:20671652-Down-Regulation,
pubmed-meshheading:20671652-Female,
pubmed-meshheading:20671652-Greece,
pubmed-meshheading:20671652-Heptanoic Acids,
pubmed-meshheading:20671652-Humans,
pubmed-meshheading:20671652-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:20671652-Kaplan-Meier Estimate,
pubmed-meshheading:20671652-Lipoproteins, LDL,
pubmed-meshheading:20671652-Male,
pubmed-meshheading:20671652-Middle Aged,
pubmed-meshheading:20671652-Proportional Hazards Models,
pubmed-meshheading:20671652-Prospective Studies,
pubmed-meshheading:20671652-Pyrroles,
pubmed-meshheading:20671652-Recurrence,
pubmed-meshheading:20671652-Risk Assessment,
pubmed-meshheading:20671652-Risk Factors,
pubmed-meshheading:20671652-Severity of Illness Index,
pubmed-meshheading:20671652-Time Factors,
pubmed-meshheading:20671652-Treatment Outcome,
pubmed-meshheading:20671652-Ultrasonography, Doppler, Color,
pubmed-meshheading:20671652-Ultrasonography, Doppler, Pulsed
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty.
|
|
pubmed:affiliation |
2nd Department of Internal Medicine, General Hospital of Nikaia and Piraeus, Pireaus, Greece.
|
|
pubmed:publicationType |
Journal Article
|
